Pàgina inicial > Articles > Resultats de la cerca: càncer.

Articles

  Consells de cerca
Cerca simple
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:

No s'ha trobat cap coincidència exacta per cancer., però canviant-lo per cancer ...
Articles 756 registres trobats  inicianterior122 - 131següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
122.
18 p, 1.9 MB Purine Nucleotide Alterations in Tumoral Cell Lines Maintained with Physiological Levels of Folic Acid / Cano-Estrada, Claudia (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; de Benito-Gómez, Lidia (Hospital Universitari de Bellvitge) ; Escudero-Ferruz, Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Ontiveros, Neus (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Iglesias-Serret, Daniel (Universitat de Vic - Universitat Central de Catalunya) ; López Riba, José M. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Most cancer cells have an increased synthesis of purine nucleotides to fulfil their enhanced division rate. The de novo synthesis of purines requires folic acid in the form of N 10 -formyltetrahydrofolate (10-formyl-THF). [...]
2023 - 10.3390/ijms241612573
International journal of molecular sciences, Vol. 24 (august 2023)  
Registre complet - Creative Commons
123.
12 p, 843.6 KB Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy / Zhang, Xuanye (Sun Yat-sen University Cancer Center) ; Tian, Dan (Guangdong Academy of Medical Sciences) ; Chen, Yue (The Eighth Affiliated Hospital of Sun Yat-sen University) ; Chen, Chen (Sun Yat-sen University Cancer Center) ; He, Li-Na (Sun Yat-sen University Cancer Center) ; Zhou, Yixin (Sun Yat-sen University Cancer Center) ; Li, Haifeng (Sun Yat-sen University Cancer Center) ; Lin, Zuan (Sun Yat-sen University Cancer Center) ; Chen, Tao (Sun Yat-sen University Cancer Center) ; Wang, Yuhong (Sun Yat-sen University Cancer Center) ; Russo, Alessandro (A.O. Papardo) ; Nadal, Ernest (Hospital Universitari de Bellvitge) ; Passiglia, Francesco (S. Luigi Gonzaga Hospital) ; Soo, Ross Andrew (National University Health System) ; Watanabe, Satoshi (Niigata University Graduate School of Medical and Dental Sciences) ; Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Oh, In-Jae (Hwasun Hospital) ; Fu, Sha (Sun Yat-sen University) ; Hong, Shaodong (Sun Yat-sen University Cancer Center) ; Zhang, Li (Sun Yat-sen University Cancer Center) ; Universitat Autònoma de Barcelona
The aim of this study was to evaluate the safety and survival outcomes of anti-programmed cell death (PD)-1/programmed cell death-ligand 1 (PD-L1) monotherapy in patients with advanced non-small cell lung cancer (NSCLC) and different hepatitis B virus (HBV) infection status. [...]
2021 - 10.21037/tlcr-21-455
Translational Lung Cancer Research, Vol. 10 (july 2021) , p. 3191-3202  
Registre complet - Creative Commons
124.
7 p, 537.4 KB Intraoperative irradiation in breast cancer : preliminary results in 80 patients as partial breast irradiation or anticipated boost prior to hypo-fractionated whole breast irradiation / Li, X. (Universitat Autònoma de Barcelona) ; Sanz, Javier (Hospital del Mar (Barcelona, Catalunya)) ; Argudo, Núria (Hospital del Mar (Barcelona, Catalunya)) ; Vernet-Tomas, Maria (Hospital del Mar (Barcelona, Catalunya)) ; Rodríguez, N. (Hospital del Mar (Barcelona, Catalunya)) ; Torrent, L. (Hospital del Mar (Barcelona, Catalunya)) ; Fernández-Velilla, E. (Hospital del Mar (Barcelona, Catalunya)) ; Pera, O. (Hospital del Mar (Barcelona, Catalunya)) ; Huang, Y. (Universitat Autònoma de Barcelona) ; Nicolau, P. (Hospital del Mar (Barcelona, Catalunya)) ; Jiménez, M. (Hospital del Mar (Barcelona, Catalunya)) ; Segura, M. (Hospital del Mar (Barcelona, Catalunya)) ; Algara, Manuel (Hospital del Mar (Barcelona, Catalunya))
To present the first results of intraoperative irradiation (IORT) in breast cancer with a low-energy photon system used as partial breast irradiation (PBI) or as an anticipated boost before whole breast hypo-fractionated irradiation (IORT + WBI), concerning tolerance, side effects, quality of life, and patient-reported outcomes. [...]
2021 - 10.1007/s12094-021-02728-0
Clinical & Translational Oncology, Vol. 24 (november 2021) , p. 829-835  
Registre complet - Creative Commons
125.
8 p, 1.0 MB Expression Patterns of miR181a and miR30d in Patients with Breast Cancer / Tavakolpournegari, Alireza (Islamic Azad University) ; Hashemi, Mehrdad (Islamic Azad University) ; Zare Karizi, Shohreh (Islamic Azad University) ; Matin Ahmadi, Arash (Nicolaus Copernicus University) ; Bidooki, Seyed Hesamoddin (University of Zaragoza) ; Banaei, Gooya (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
One of the important molecular pathways in breast cancer is the PTEN-PI3K-AKT pathway. Any change in the activity of the PTEN gene can alter the PI3K-AKT pathway. Moreover, there are subsets of genes and pathways their expression changes by post-transcriptional regulations. [...]
2022 - 10.18502/ijph.v51i7.10093
Iranian Journal of Public Health, Vol. 51, Num. 7 (July 2022) , p. 1594-1601  
Registre complet - Creative Commons
126.
14 p, 2.2 MB A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Regis, Lucas (Hospital Universitari Vall d'Hebron) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Mendez, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Early detection of PCa (PCa) has evolved towards clinically significant PCa (csPCa) after the spread of pre-biopsy multiparametric magnetic resonance imaging (mpMRI). However, PCa suspicion remains based on prostate-specific antigen (PSA) elevation and/or abnormal digital rectal examination (DRE). [...]
2022 - 10.3390/cancers14205100
Cancers, Vol. 14 (october 2022)  
Registre complet - Creative Commons
127.
9 p, 1.7 MB Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer / Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ; Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ; Triquell, Marina (Hospital Universitari Vall d'Hebron) ; Campistol, Miriam (Hospital Universitari Vall d'Hebron) ; Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ; Planas, Jacques (Hospital Universitari Vall d'Hebron) ; Méndez Fernández, Olga (Hospital Universitari Vall d'Hebron) ; Esteban, Luis M. (Universidad de Zaragoza) ; Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The Barcelona magnetic resonance imaging (MRI)-based risk calculator (BCN MRI-RC) exhibited, in the analysed population, better behaviour than the Rotterdam-MRI risk calculator to improve candidate selection for prostate biopsy for the early detection of clinically significant prostate cancer. [...]
2023 - 10.1016/j.euros.2023.03.013
European Urology Open Science, Vol. 53 (may 2023) , p. 46-54  
Registre complet - Creative Commons
128.
16 p, 616.9 KB Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer : An Integrative View / Lee-Rueckert, Miriam (Wihuri Research Institute) ; Lappalainen, Jani (Wihuri Research Institute) ; Kovanen, Petri T. (Wihuri Research Institute) ; Escolà-Gil, Joan Carles (Institut d'Investigació Biomèdica Sant Pau)
Atherosclerotic arterial plaques and malignant solid tumors contain macrophages, which participate in anaerobic metabolism, acidosis, and inflammatory processes inherent in the development of either disease. [...]
2022 - 10.3389/fcvm.2022.777822
Frontiers in Cardiovascular Medicine, Vol. 9 (February 2022) , p. 777822  
Registre complet - Creative Commons
129.
26 p, 520.5 KB Combining Molecular, Imaging, and Clinical Data Analysis for Predicting Cancer Prognosis / Lobato-Delgado, Bárbara (Institut d'Investigació Biomèdica Sant Pau) ; Priego-Torres, Blanca (Instituto de Investigación e Innovación Biomédica de Cádiz) ; Sanchez-Morillo, Daniel (Instituto de Investigación e Innovación Biomédica de Cádiz)
Cancer is one of the most detrimental diseases globally. Accordingly, the prognosis prediction of cancer patients has become a field of interest. In this review, we have gathered 43 state-of-the-art scientific papers published in the last 6 years that built cancer prognosis predictive models using multimodal data. [...]
2022 - 10.3390/cancers14133215
Cancers, Vol. 14 Núm. 13 (July 2022) , p. 3215  
Registre complet - Creative Commons
130.
7 p, 264.1 KB European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment / Lee, G.A. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Aktaa, S. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Baker, E. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ; Gale, C.P. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ; Yaseen, I.F. (Scientific Council of Cardiology. Iraqi Board for Medical Specializations) ; Gulati, G. (Oslo University Hospital (Oslo, Noruega)) ; Asteggiano, R. (LARC (Laboratorio Analisi e Ricerca Clinica)) ; Szmit, S. (Institute of Hematology and Transfusion Medicine) ; Cohen-Solal, A. (Cardiology Department. Hôpitaux de Paris. Hôpital Lariboisière 2 Rue Ambroise Paré) ; Abdin, A. (Department of Internal Medicine III. Cardiology. Angiology. Intensive Care Medicine. Saarland University Medical Center) ; Jurczak, W. (MSC National Research Institute of Oncology) ; Garrido, Pilar (Jefe Servicio Oncología Médica. Hospital Ramón y Cajal) ; Sverdlov, A.L. (Newcastle Centre of Excellence in Cardio-Oncology. Calvary Mater Newcastle. Hunter Medical Research Institute. John Hunter Hospital. University of Newcastle) ; Tocchetti, C.G. (Cardio-Oncology Unit. Department of Translational Medical Sciences (DISMET). Center for Basic and Clinical Immunology Research (CISI). Interdepartmental Center for Clinical and Translational Research (CIRCET). Interdepartmental Hypertension Research Center (CIRIAPA). Federico II University) ; Barac, A. (Cardio-oncology Program. MedStar Heart and Vascular Institute) ; Parrini, I. (Department of Cardiology. Mauriziano Hospital) ; Zamorano, P. (Hospital Universitario Ramón y Cajal (Madrid)) ; Iakobishvili, Z. (Faculty of Health Sciences. Ben Gurion University of the Negev) ; Pudil, R. (University Hospital Hradec Králové. Sokolská) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Kirby, A.M. (Royal Marsden NHS Trust. Institute of Cancer Research) ; Blaes, A.H. (Division of Hematology/Oncology/Transplantation. University of Minnesota) ; Farmakis, D. (University of Cyprus Medical School) ; Curigliano, Giuseppe (IRCCS. European Institute of Oncology) ; Stephens, R. (Patient Advocate) ; Lyon, A.R. (National Heart and Lung Institute. Imperial College London. Cardio-Oncology Service. Royal Brompton Hospital) ; Lopez-Fernandez, T. (Hospital Universitario La Paz. Instituto de Investigación IdiPAZ. Servicio de Cardiología)
Aims To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. Methods and results We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. [...]
2023 - 10.1093/ehjqcco/qcac070
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9 Núm. 1 (january 2023) , p. 1-7  
Registre complet - Creative Commons
131.
12 p, 1.1 MB Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer / Lara, Pedro C. (Centro Oncológico Integral de Canarias. Hospital Universitario San Roque. Universidad Fernando Pessoa Canarias) ; Rodríguez-Melcón, Juan I. (Hospital Universitario de Gran Canaria Doctor Negrín. Oncología Radioterápica) ; Palacios-Eito, Amalia (Hospital Universitario "Reina Sofía" (Còrdova). Instituto Maimónides de Investigación Biomédica de Córdoba. Oncología Radioterápica) ; Lozano, Antonio (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Hervás-Morón, Asunción (Hospital Ramón y Cajal. Oncología Radioterápica) ; Villafranca, Elena (Hospital Universitario de Navarra. Oncología Radioterápica) ; Gómez-Iturriaga, Alfonso (Hospital Universitario Cruces. BioCruces. Oncología Radioterápica) ; Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Maldonado, Xavier (Vall d'Hebron Institut d'Oncologia)
Background: Intermediate-risk prostate cancer (PCa) is usually treated by a combination of external beam radiation therapy (EBRT) and a short course of androgen deprivation therapy (ADT). ADT is associated with multiple side effects, including weight gain, loss of libido, and hot flashes. [...]
2022 - 10.3389/fonc.2022.891886
Frontiers in Oncology, Vol. 12 (July 2022) , p. 891886  
Registre complet - Creative Commons

Articles : 756 registres trobats   inicianterior122 - 131següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem